Latest AB Science News & Updates

See the latest news and media coverage for AB Science. We track all announcements, press releases, and industry mentions in real time, all in one place.

AB Science

Biopharmaceutical company developing small molecule drugs

ab-science.com

Last updated Today

Latest news about AB Science

In short: AB Science streamlined its operations to focus on its lead programs, masitinib and AB8939, while securing several million euros in funding.

Company announcements

July 10 AB Science

AB Science narrows clinical focus to two programs

It discontinues non-priority studies to concentrate on AB8939 for AML and masitinib for ALS.

July 8 AB Science

AB Science restructures its Board of Directors governance

The move appoints Stéphane Ledermann as Chairman and CEO to lead a new development phase.

June 17 AB Science

AB Science obtains US patent for masitinib in prostate cancer

The patent protects masitinib for treating metastatic castrate-resistant prostate cancer until 2042.

May 13 AB Science

AB Science reports 2025 annual financial results

The company reported its revenues for the year 2025 and provided an activity update.

Media coverage

June 17 The Manila Times

AB Science patent for masitinib in the treatment of metastatic castrate resistant prostate cancer formally granted in the United States with a protection until 2042

This new US patent adds to the IP coverage already granted in Europe (EP4175639). Counterpart patent applications have also been filed in other major international...

June 9 Yahoo Finance

AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS

PRESS RELEASE AB SCIENCE IS INVITED TO PRESENT AT THE 2026 ENCALS ANNUAL MEETING THE SURVIVAL DATA FROM MASITINIB CLINICAL PROGRAM IN AMYOTROPHIC LATERAL SCLEROSIS...

May 13 Markets Insider

AB Science reports its revenues for the year 2025 and provides an update on its activities

PRESS RELEASEAB SCIENCE PRESENTS ITS ANNUAL FINANCIAL RESULTS AS OF 31 DECEMBER 2025 AND KEY EVENTS FOR THE PERIODFinancial and...

April 29 Taiwan News

AB Science announces the successful completion of a EUR 3.2 million private placement

The Company intends to use the net proceeds of the Private Placement to finance its ongoing activities, with a focus on the clinical development of...

Never miss news about AB Science

Track AB Science and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.